Edwards Lifesciences Corp (EW)

Days of sales outstanding (DSO)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
DSO	days	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

Based on the provided data, the days of sales outstanding (DSO) for Edwards Lifesciences Corp are not available or are represented as "— days" for the periods from March 31, 2020, to December 31, 2024. DSO is a metric that measures the average number of days it takes a company to collect revenue after a sale has been made.

The absence of specific DSO figures may suggest that the company's financial statements or disclosures do not contain this particular ratio, or the data may not have been made publicly available in the source provided. Without the actual DSO values, it is challenging to evaluate the effectiveness of Edwards Lifesciences' accounts receivable management and its impact on the company's liquidity and working capital.

To conduct a more comprehensive analysis of Edwards Lifesciences Corp's DSO, it would be necessary to obtain the specific values for each reporting period or refer to additional sources that provide insights into the company's accounts receivable turnover and collection efficiency. Understanding the trends and fluctuations in DSO over time could provide valuable information regarding the company's sales cycles, credit policies, and overall financial performance.